Profile data is unavailable for this security.
About the company
Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is lightweight, specifically designed to replace metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLOR can deliver up to 95% pure oxygen to patients 24 hours a day, seven days a week. The Company is focused on developing medical devices who suffer from chronic lung diseases, such as the Chronic Obstructive Pulmonary Disease (COPD), respiratory distress caused by COVID-19, and many other respiratory disorders. It is also focused on developing, licensing and manufacturing portable oxygen concentrators for use in treating lung diseases with its oxygen platform technologies, to include recreational and industrial oxygen concentrators, wound care devices, drug delivery devices and more.
- Revenue in GBP (TTM)966.06k
- Net income in GBP-8.03m
- Incorporated2015
- Employees24.00
- LocationBelluscura PLC15 Fetter LaneLONDON EC4A 1BWUnited KingdomGBR
- Phone+1 214 396 8313
- Websitehttps://www.belluscura.com/
Mergers & acquisitions
| Acquired company | BELL:LSE since announced | Transaction value |
|---|---|---|
| TMT Acquisition PLC | -75.41% | 6.77m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deltex Medical Group plc | 1.78m | -1.28m | 2.46m | 37.00 | -- | 0.7299 | -- | 1.39 | -0.0012 | -0.0012 | 0.0015 | 0.0018 | 0.2974 | 0.8471 | 5.61 | 48,000.00 | -21.47 | -14.66 | -29.13 | -21.81 | 63.34 | 71.84 | -72.18 | -32.93 | 1.13 | -2.98 | 0.3793 | -- | -28.44 | -18.55 | -11.97 | -- | 9.78 | -- |
| Surgical Innovations Group Plc | 12.01m | -509.00k | 4.66m | 90.00 | -- | 0.4449 | 18.81 | 0.3882 | -0.0005 | -0.0005 | 0.0129 | 0.0112 | 0.8032 | 2.85 | 5.89 | -- | -3.40 | -8.19 | -4.18 | -9.94 | 28.70 | 32.51 | -4.24 | -13.31 | 1.23 | -4.45 | 0.1368 | -- | 5.94 | 1.84 | -292.80 | -- | 7.20 | -- |
| Myhealthchecked PLC | 14.95m | 189.00k | 5.46m | 15.00 | 28.30 | 0.6387 | 16.50 | 0.3654 | 0.0037 | 0.0037 | 0.2885 | 0.1644 | 1.26 | 5.81 | 7.95 | 996,400.00 | 1.59 | -20.09 | 2.21 | -28.23 | 27.79 | 22.62 | 1.26 | -13.42 | 3.53 | -- | 0.0047 | -- | 36.26 | 190.36 | -24.30 | -- | -12.80 | -- |
| Rua Life Sciences PLC | 1.87m | -1.87m | 6.67m | 40.00 | -- | 0.6387 | -- | 3.57 | -0.0843 | -0.0843 | 0.0843 | 0.1683 | 0.3293 | 3.26 | 4.80 | 46,725.00 | -32.95 | -25.97 | -36.33 | -28.26 | 81.97 | -- | -100.05 | -110.53 | 2.40 | -61.71 | 0.1065 | -- | 34.09 | 40.08 | 3.10 | -- | 94.82 | -- |
| Advanced Oncotherapy PLC | 0.00 | -32.60m | 9.50m | 174.00 | -- | 0.1306 | -- | -- | -0.0819 | -0.0819 | 0.00 | 0.134 | 0.00 | 0.00 | -- | 0.00 | -23.34 | -25.83 | -29.05 | -30.15 | -- | -- | -- | -- | 0.1293 | -4.06 | 0.4968 | -- | -- | -- | -16.57 | -- | -0.8064 | -- |
| Belluscura PLC | 966.06k | -8.03m | 12.28m | 24.00 | -- | 0.4986 | -- | 12.71 | -0.0649 | -0.0649 | 0.0078 | 0.1492 | 0.0445 | 0.2197 | 0.3099 | 40,252.69 | -36.98 | -35.98 | -40.59 | -39.17 | -32.24 | -40.01 | -831.69 | -838.02 | 4.17 | -3.43 | 0.00 | -- | 232.62 | 31.09 | -56.38 | -- | 30.90 | -- |
| Ondine Biomedical Inc | 472.80k | -11.00m | 15.15m | 43.00 | -- | 5.37 | -- | 32.04 | -0.0565 | -0.0565 | 0.0024 | 0.0125 | 0.0492 | 0.3584 | 5.54 | 10,995.23 | -114.33 | -- | -135.98 | -- | 49.00 | -- | -2,326.12 | -- | 1.93 | -- | 0.1961 | -- | -75.17 | -- | 61.32 | -- | -- | -- |
| Inspiration Healthcare Group PLC | 41.08m | -550.00k | 21.49m | 210.00 | -- | 0.6102 | 12.77 | 0.5232 | -0.0081 | -0.0081 | 0.603 | 0.5163 | 0.7879 | 2.32 | 4.76 | 195,619.00 | -1.05 | 6.14 | -1.25 | 7.60 | 45.59 | 47.42 | -1.34 | 6.00 | 1.50 | -0.1289 | 0.2317 | -- | 0.4458 | 21.62 | -93.58 | -25.97 | 52.54 | -- |
| Inspecs Group PLC | 203.29m | -997.00k | 52.87m | 1.67k | -- | 0.5107 | 4.39 | 0.2601 | -0.0109 | -0.0109 | 1.94 | 1.02 | 0.8864 | 2.24 | 8.68 | 121,513.40 | -0.4347 | -1.48 | -0.6975 | -2.15 | 50.94 | 48.50 | -0.4904 | -1.97 | 0.8677 | 1.54 | 0.375 | -- | 1.16 | 36.45 | 84.22 | -- | 51.04 | -- |
| SDI Group PLC | 68.07m | 1.61m | 57.50m | 489.00 | 36.23 | 1.32 | 9.74 | 0.8447 | 0.0152 | 0.0152 | 0.6528 | 0.4174 | 0.7958 | 2.08 | 6.29 | 139,206.50 | 1.93 | 8.83 | 2.34 | 11.43 | 63.34 | 64.57 | 2.43 | 10.64 | 1.14 | 5.86 | 0.3311 | 0.00 | 36.09 | 36.05 | -48.68 | 19.11 | 11.86 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Dowgate Wealth Ltd.as of 04 Apr 2024 | 7.48m | 4.55% |
| Lombard Odier Asset Management (Europe) Ltd.as of 15 Nov 2023 | 6.45m | 3.93% |
| Rathbones Asset Management Ltd.as of 09 Feb 2024 | 2.23m | 1.35% |
| Avellemy Ltd.as of 29 Mar 2024 | 574.88k | 0.35% |
